IMEXF (Imagin Medical) Total Liabilities: $9.85 Mil (As of Jun. 2023)


What is Imagin Medical Total Liabilities?

Imagin Medical IMEXF -99.00% Total Liabilities is $9.85 Mil as of Jun. 2023.

Imagin Medical's Total Liabilities for the quarter that ended in Jun. 2023 was $9.85 Mil.

Imagin Medical's quarterly Total Liabilities increased from Dec. 2022 ($10.68 Mil) to Mar. 2023 ($11.19 Mil) but then declined from Mar. 2023 ($11.19 Mil) to Jun. 2023 ($9.85 Mil).

Imagin Medical's annual Total Liabilities increased from Sep. 2020 ($0.42 Mil) to Sep. 2021 ($9.72 Mil) and increased from Sep. 2021 ($9.72 Mil) to Sep. 2022 ($11.01 Mil).

Imagin Medical Total Liabilities Historical Data

* Premium members only.

The historical data trend for Imagin Medical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imagin Medical Total Liabilities Chart

Imagin Medical Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.29 0.42 9.72 11.01

Imagin Medical Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.33 11.01 10.68 11.19 9.85

Imagin Medical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Imagin Medical's Total Liabilities for the fiscal year that ended in Sep. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=11.01+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=11.01

Total Liabilities=Total Assets (A: Sep. 2022 )-Total Equity (A: Sep. 2022 )
=1.013--9.997
=11.01

Imagin Medical's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9.846+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=9.85

Total Liabilities=Total Assets (Q: Jun. 2023 )-Total Equity (Q: Jun. 2023 )
=0.841--9.005
=9.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $9.85 Mil mean?
Imagin Medical (IMEXF) has a Total Liabilities of $9.85 Mil as of Jun. 2023. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Imagin Medical and its competitors.
Is Imagin Medical's Total Liabilities too high?
Imagin Medical's current Total Liabilities is $9.85 Mil.
How does Imagin Medical's Total Liabilities compare to ABT and SYK?
Imagin Medical's Total Liabilities of $9.85 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Imagin Medical and its competitors. Imagin Medical's current Total Liabilities is $9.85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imagin Medical stock overvalued right now?
Imagin Medical (IMEXF) has a current Total Liabilities of $9.85 Mil. The current Total Liabilities is $9.85 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Imagin Medical (IMEXF), the current Total Liabilities is $9.85 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imagin Medical Business Description

Address 890 West Pender Street, Suite 600, Vancouver, BC, CAN, V6C 1J9
Imagin Medical Inc is a Urologic Oncology company developing technologies to visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery. The company's first product, the i/Blue Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease. Imagin's follow-on product, the enCAGE Coil is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.